Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type

NCT07514923 is registered in ClinicalTrials.gov with yilong Wang as lead sponsor.

NCT NCT07514923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type
Lead sponsor
yilong Wang
Phase
Phase 1
Overall status
Recruiting
Start date
June 10, 2026
Completion date
October 30, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy - cerebellar subtype (msa-c)